Brett Sandercock, Chief Financial Officer at RESMED INC (RMD), sold 1,000 shares at $233.47 ($233K) on 2024-10-08, disclosed to the SEC on 2024-10-09.
Scheduled sale ($233k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RMD | SELL | 2026-02-03 | $257K | — | Filing → |
| RMD | SELL | 2026-01-05 | $242K | — | Filing → |
| RMD | SELL | 2025-12-02 | $244K | — | Filing → |